Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Illumina Advises Stockholders To Take No Action In Response To Roche's New Offer

RELATED NEWS
Trade ILMN now with 

Illumina, Inc. (ILMN: Quote) suggested that its stockholders take no action at this time in response to announcement by Roche Holding AG (RHHBY.PK) that it is now offering to acquire Illumina for $51.00 per share in cash.

Earlier, on February 7, 2012, Illumina's Board of Directors rejected Roche's $44.50 per share cash tender offer and recommended that stockholders not tender their shares.

Illumina stated that its Board of Directors will thoroughly review Roche's revised proposal and make a recommendation to stockholders regarding the proposal in due course.

Click here to receive FREE breaking news email alerts for Illumina Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.